These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12415266)

  • 21. Indirect allorecognition: not simple but effective.
    Bolton EM; Bradley JA; Pettigrew GJ
    Transplantation; 2008 Mar; 85(5):667-9. PubMed ID: 18337656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory cells in transplantation.
    Wood KJ; Ushigome H; Karim M; Bushell A; Hori S; Sakaguchi S
    Novartis Found Symp; 2003; 252():177-88; discussion 188-93, 203-10. PubMed ID: 14609219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo.
    Serre K; Giraudo L; Siret C; Leserman L; Machy P
    Eur J Immunol; 2006 Jun; 36(6):1386-97. PubMed ID: 16673447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+ T-cell-independent rejection of corneal allografts.
    Niederkorn JY; Stevens C; Mellon J; Mayhew E
    Transplantation; 2006 Apr; 81(8):1171-8. PubMed ID: 16641604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aortic allograft vasculopathy is mediated by CD8(+) T cells in Cyclosporin A immunosuppressed mice.
    Vessie EL; Hirsch GM; Lee TD
    Transpl Immunol; 2005 Oct; 15(1):35-44. PubMed ID: 16223671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graft rejection mediated by CD4+ T cells via indirect recognition of alloantigen is associated with a dominant Th2 response.
    Csencsits K; Wood SC; Lu G; Magee JC; Eichwald EJ; Chang CH; Bishop DK
    Eur J Immunol; 2005 Mar; 35(3):843-51. PubMed ID: 15714582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunologic aspects of cellular therapy].
    Sukhikh GT; Bogdanova IM; Malaĭtsev VV
    Biull Eksp Biol Med; 1998 Feb; 125(2):124-9. PubMed ID: 9559117
    [No Abstract]   [Full Text] [Related]  

  • 30. CD8 lethargy in the absence of CD4 help.
    Bourgeois C; Veiga-Fernandes H; Joret AM; Rocha B; Tanchot C
    Eur J Immunol; 2002 Aug; 32(8):2199-207. PubMed ID: 12209632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction and analysis of lethal graft-versus-host disease in tolerant mice.
    Végh P; Vizler C; Jánossy T; Savelkoul HF; Nyirati I; Benner R
    Transplant Proc; 1996 Jun; 28(3):1241-3. PubMed ID: 8658641
    [No Abstract]   [Full Text] [Related]  

  • 32. Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway.
    Valujskikh A; Lantz O; Celli S; Matzinger P; Heeger PS
    Nat Immunol; 2002 Sep; 3(9):844-51. PubMed ID: 12172545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The alloresponse.
    Hernandez-Fuentes MP; Baker RJ; Lechler RI
    Rev Immunogenet; 1999; 1(3):282-96. PubMed ID: 11256420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alloreactivity and apoptosis in graft rejection and transplantation tolerance.
    Zavazava N; Kabelitz D
    J Leukoc Biol; 2000 Aug; 68(2):167-74. PubMed ID: 10947059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of T cells in the destruction of xenografts within cell-impermeable membranes.
    Loudovaris T; Charlton B; Mandel T
    Transplant Proc; 1992 Dec; 24(6):2938. PubMed ID: 1361268
    [No Abstract]   [Full Text] [Related]  

  • 36. Tolerance and suppression in a primed immune system.
    Marshall SE; Cobbold SP; Davies JD; Martin GM; Phillips JM; Waldmann H
    Transplantation; 1996 Dec; 62(11):1614-21. PubMed ID: 8970617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Embryonic pig pancreatic tissue for the treatment of diabetes: potential role of immune suppression with "off-the-shelf" third-party regulatory T cells.
    Tchorsh-Yutsis D; Zlotnikov Klionsky Y; Bachar-Lustig E; Aronovich A; Feine I; Shezen E; Rosen C; Bitcover R; Eventov-Friedman S; Katchman H; Zangi L; Tal O; Cohen S; Reisner Y
    Transplantation; 2011 Feb; 91(4):398-405. PubMed ID: 21192322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of tolerance using ultraviolet-irradiated cells.
    Agostino M; Prowse SJ; Lafferty KJ
    Transplant Proc; 1984 Aug; 16(4):959-60. PubMed ID: 6431670
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of tolerance to alloantigen.
    Witzke O; Barbara JA; Wood KJ
    Rev Immunogenet; 1999; 1(3):374-86. PubMed ID: 11256428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory cells and cell signatures in clinical transplantation tolerance.
    Newell KA; Phippard D; Turka LA
    Curr Opin Immunol; 2011 Oct; 23(5):655-9. PubMed ID: 21982510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.